tiprankstipranks
Trending News
More News >
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market

RaQualia Pharma Inc. (4579) Income Statement

Compare
1 Followers

RaQualia Pharma Inc. Income Statement

Last quarter (Q3 2025), RaQualia Pharma Inc.'s total revenue was ¥775.05M, a decrease of -19.13% from the same quarter last year. In Q3, RaQualia Pharma Inc.'s net income was ¥-214.24M. See RaQualia Pharma Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 3.11B¥ 1.90B¥ 2.92B¥ 2.78B¥ 1.11B
Gross Profit
¥ 2.48B¥ 1.66B¥ 2.69B¥ 2.46B¥ 969.29M
Operating Expenses
¥ 2.70B¥ 1.99B¥ 1.82B¥ 1.75B¥ 1.46B
Depreciation and Amortization
¥ 401.65M¥ 175.56M¥ 147.73M¥ 141.56M¥ 124.25M
EBITDA
¥ 188.27M¥ -111.80M¥ 1.00B¥ 1.02B¥ -403.25M
Operating Income
¥ -213.38M¥ -337.37M¥ 866.24M¥ 707.86M¥ -486.08M
Other Income/Expenses
¥ -144.35M¥ 43.32M¥ -15.22M¥ 172.72M¥ -41.86M
Pretax Income
¥ -357.73M¥ -294.05M¥ 851.01M¥ 880.58M¥ -527.94M
Net Income
¥ -495.03M¥ -323.66M¥ 723.39M¥ 755.79M¥ -606.99M
Per Share Metrics
Basic EPS
¥ -22.87¥ -14.98¥ 34.50¥ 36.07¥ -28.97
Diluted EPS
¥ -22.87¥ -14.98¥ 34.47¥ 36.04¥ -28.97
Weighted Average Shares Outstanding
21.65M 21.61M 20.97M 20.95M 20.95M
Weighted Average Shares Outstanding (Diluted)
21.65M 21.61M 20.98M 20.97M 20.95M
Currency in JPY

RaQualia Pharma Inc. Earnings and Revenue History